Advancing Oncology & Specialty Care Through Global Partnerships
A focused pharmaceutical platform dedicated to oncology, biosimilars and specialty medicines — identifying high-value opportunities, partnering with established international companies, and building sustainable pathways for registration, market access and commercialization.
Specialty Medicines. Strategic Partnerships. Better Access.
Uniphar Pakistan is a pharmaceutical business focused on building access to high-quality specialty medicines, with a strategic emphasis on oncology, biosimilars and complex therapies.
Our strategy is centered on bringing quality-driven therapies to markets where access, affordability and reliable supply matter. Through strategic partnerships with Varifarma and Kemex, both Argentina-based pharmaceutical companies, Uniphar is developing a differentiated portfolio across oncology and complex therapies.
More about Uniphar Pakistan- Oncology medicines and supportive care
- Selected biosimilars and complex biologic opportunities
- Specialty pharmaceuticals and hospital products
- International licensing and commercialization partnerships
- Regulatory registration and market access
- Commercialization, distribution and market development
Where we concentrate our expertise
We build portfolios around high-need therapeutic areas rather than pursuing a broad, undifferentiated generic portfolio.
Oncology
Established chemotherapy, targeted therapies, onco-hematology and supportive care.
Learn more Growth areaBiosimilars & Complex Biologics
Oncology biosimilars, monoclonal antibodies and high-value complex molecules.
Learn more SelectiveSpecialty Pharmaceuticals
Differentiated specialty and hospital medicines with meaningful healthcare impact.
Learn moreUniphar Pakistan × Varifarma × Kemex
Combining international product and manufacturing capabilities with Uniphar’s market development, regulatory and commercialization capabilities.
Experience that turns opportunities into sustainable businesses
Business development
Deep pharmaceutical business-development experience.
Regulatory insight
International market and regulatory understanding.
Manufacturing access
Access to specialized international manufacturing partners.
Commercial execution
Commercial execution and distributor development.
Portfolio building
Portfolio building with a long-term market perspective.
Institutional supply
Commercial operations and institutional supply.
An integrated pharmaceutical model
We participate in building pharmaceutical businesses — not simply providing reports.
- Step 1
Identify
Identify products, technologies and market opportunities aligned with our strategic focus.
- Step 2
Evaluate
Assess scientific, regulatory, manufacturing and commercial feasibility.
- Step 3
Partner
Establish licensing, supply, distribution or strategic partnership arrangements.
- Step 4
Register
Execute regulatory submissions and market-access requirements.
- Step 5
Launch
Build the commercial plan, channel strategy and launch execution.
- Step 6
Scale
Expand products, indications and geographies through disciplined portfolio management.
A recognized specialty-pharma platform for Pakistan and beyond
To build Uniphar Pakistan into a recognized specialty-pharma platform serving oncology and complex therapeutic needs through trusted global partnerships, strong regulatory standards and disciplined commercial execution.
Why partner with UnipharExplore a Partnership
Let’s build the next generation of specialty pharmaceutical opportunities together.